H. Lundbeck A/S Navne-Aktier A DK 1

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

25.45%

Market Cap

4.33 Bil.

P/E Ratio

11.25

Dividend Yield

3.18 %

Earnings per Share

0.43 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE4.875 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 04:50:57 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW4.8954.855
PREV. DAY'S PRICE4.88 (07/21)
CHANGE DAY BEFORE
-0.00
-0.10 %
52 WEEK HIGH / LOW5.31 (01/16)3.825 (08/01)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
0.310.430.43--
DIVIDENDS PER SHARE
0.090.130.15--
DIVIDEND YIELD IN %
2.44 %2.84 %3.18 %--
DIVIDEND GROWTH IN %
20.26 %35.58 %21.18 %--
PRICE - EARNINGS RATIO
12.4410.5411.25--
PRICE - BOOK RATIO
1.291.321.44--
PRICE - SALES RATIO
1.431.501.47--
PRICE - CASH FLOW RATIO
6.989.737.33--
Further Key Figures

Master Data

WKN
A3DMBU
ISIN
DK0061804697
SYMBOL
LDBB
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
H.Lundbeck
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
4.33 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.99 %
0.41 %
5.29 %
-3.75 %
25.45 %
22.37 %
-4.98 %
2.31 %
HIGH4.925.025.035.295.315.555.555.31
LOW4.784.784.514.203.833.170.874.20

Dividende

pro Aktie

Company profile

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.